News for Rocket Pharmaceuticals, Inc. (RCKT)

Insightful analysis of Rocket Pharmaceuticals Inc's (RCKT) financial health and strategic positioning.Comprehensive SWOT analysis to guide investors and stakeh

RCKT incurs a narrower-than-expected fourth-quarter 2024 loss. The company provides updates on its pipeline candidates.

[url="]Rocket Pharmaceuticals, Inc.[/url] (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic ther

We recently published a list of the 10 Oversold Pharma Stocks to Buy According to Analysts. In this article, we are going to take a look at where Immunovant, Inc.

We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a look at where Immunovant, Inc.

Rocket Pharmaceuticals, Inc.'s innovative therapies show promise after FDA setbacks. With potential $1B+ markets, RCKT offers opportunity. Click for my RCKT update.

Baron Opportunity Fund increased in the fourth quarter of 2024, outperforming its benchmark, the Russell 3000 Growth Index.

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Immunovant, Inc.

Rocket Pharmaceuticals (RCKT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a...

Rocket Pharmaceuticals Inc (RCKT), a late-stage biotechnology company focused on developing genetic therapies for rare disorders, announced its participation in

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article, we are going to take a look at where Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) stands against the other...

Rocket Pharmaceuticals Inc (RCKT), a late-stage biotechnology company focused on developing genetic therapies for rare disorders, has announced the pricing of a

[url="]Rocket Pharmaceuticals, Inc.[/url] (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic ther

Rocket Pharmaceuticals, Inc. (RCKT), a late-stage biotechnology company, Wednesday said it has priced an upsized public offering of 13.2 million shares at $12.50 per share.

Rocket Pharmaceuticals sets $12.50 share price for offering

After-hours movers: GM, Stitch Fix, Dave & Buster's, GME and more

Galapagos NV (GLPG) experienced a significant stock price increase of 5.17%, reaching $28.29 per share with a trading volume of 302,700 shares and a turnover ra

Capricor Therapeutics, Inc. (CAPR) experienced a notable stock price increase, rising by 5.40%. The stock is currently priced at $20.09 per share with a trading